PhaseBio Pharmaceuticals, Inc. was a biopharmaceutical company based in Morrisville, NC, specializing in the development of innovative therapies. Unfortunately, the company filed for Chapter 11 bankruptcy in October 2022 and is no longer operational.
PhaseBio Pharmaceuticals focused on research and development in areas such as elastin-like polypeptides and novel drug candidates like PB-1046 and PB-1023. Despite its bankruptcy, inquiries related to its products and assets are being directed to various entities for further information.
Generated from the website